How connected medical devices can curb COVID-19 spread in hospitals.
View as Webpage
MS Health Information Management and MS Health Informatics Information Session >>
 
 
 
Subscribe
 
 
 
Thursday May 28, 2020
 
 
Scientist looking at computer monitor
 
 

Clinical lab and drug development giant LabCorp announced this morning a new deal that will streamline its adoption of virtual clinical trials.

The company's drug development-focused contract research organization (CRO), Covance, will use digital clinical trial software maker Medable's platform to fuel its patient and site interface. This will allow participants easy access to clinical trial apps, while ensuring stronger engagement, remote data collection and system interoperability.

WHY IT MATTERS

LabCorp's Covance is among the largest drug development CROs in the world, offering a range of services across different therapeutic areas, development phases and product types. The company first unveiled its decentralized clinical trial system in late 2019, but the new deal suggests that these capabilities will be an even greater focus for the global CRO going forward.

“Working together, we can apply the full capabilities of LabCorp Diagnostics business, Covance, and our technology ecosystem to extend patient access, improve the patient experience, and accelerate timelines for clinical development,” Bill Hanlon, president of enterprise solutions at Covance, said in a statement. “We will continue to play a critical role as aggregators and integrators to provide customers with the access, flexibility, and scale necessary to enable global decentralized studies, and to rapidly innovate in ways that improve the patient experience and trial efficiency.”

Also of note, LabCorp told Reuters that it has seen a substantial number of participants dropping out of ongoing studies as a result of the ongoing COVID-19 pandemic. Decentralized digital trials would provide the company a way to keep these programs on track during the coming months.

THE LARGER TREND

Major pharmas and other drug development stakeholders are increasingly aware of the benefits digital clinical trials have to offer, so it's little surprise to see startups become increasingly active in the space. It was only weeks ago that Medable announced a $25 million funding round, which it said at the time would fuel new product development, partnerships and market adoption.

The startup is among a number of startups active in this space that includes Florence, which raised $7.1 million last fall, and Tekro, which brought in $25 million last year.

ON THE RECORD

"The LabCorp ecosystem powered by Medable leverages big data convenient research participation with home diagnostic testing and remote care and research participation," Dr. Michelle Longmire, CEO and cofounder of Medable, told MobiHealthNews in an email statement. "Patients can now leverage the full power of the ecosystem to conveniently participate in clinical trials on their own terms. We believe this advancement is paramount to broadening access to new investigational therapies and dramatically reducing clinical trial timelines."

 
Dr. Ran Balicer speaking to HIMSS
 
 

When it comes to regions around the world where health tech is in full bloom, it would be hard not to mention Israel. Today we are seeing a rise of health IT innovation and digital health companies rising from this relatively small country in the Middle East. 

That is also true when it comes to the country’s largest healthcare organization, Clalit Health Services, which is combining its swaths of patient data and artificial intelligence to move towards predictive care with actionable steps. Clalit had a leg up when it implemented this system – its integrated EMR. 

“We have had a single EMR in the community-care setting and hospital care. …[A]ll of the data is going to a central data warehouse ... where it is stored and used in order to provide predictive, proactive and preventive care to our population,” Dr. Ran Balicer, chief innovation officer of Israel’s Clalit Research Institute, said during HIMSS20 Digital’s Israel's Largest Healthcare Organization Implements Innovation at Scale

While many countries had a goal of moving toward predictive care, Israel’s healthcare structure made the switch easier. 

“We had all the ingredients to make it happen a little bit earlier and a little bit ahead of the curve as compared to ... other countries, simply because that data was there,” Balicer said. “We could take and use this data, and use a predictive model in order to have a different way to provide care to our populations. The second thing is we had responsibility for a population in the larger sense and not a necessarily on a patient specific visit approach. Everyone one of our physicians knows they're responsible. Every one of our physicians knows [their] population.” 

Keeping the end user in mind is key, he said. Success doesn’t depend solely on whether or not the tech works. 

“You have to make the right way be the easy way. You can’t make something the is over cumbersome and is a list of requests or accommodations coming from upstairs , with little heed to the daily impossible practice of GPs, and physicians and nurses in general,” Balicer said. “If you are trying to give a set of orders by email of accommodations that usually is going to fail.”

Balicer explained that clinician education is fundamental to predictive care. He gave the example of a pilot done on predicting patients with chronic kidney disease back in 2010. When a patient gets to the point of needing dialysis there is little clinicians can do to turn the condition around. If caught earlier the condition can be avoided.

The new technology could help pinpoint the time a patient was at risk for a disorder. However, just telling clinicians that a patient may or may not  develop a disorder is no use unless the prediction tool is combined with training about what to do if your patient is developing this disorder. 

The tool also has to fit into a clinician’s workflow and not take too much work. 

“I think one of the key things that made that possible was the information systems put in place made proactive care something that was feasible and intuitive. Every physician had a list of patients for proactive care and had guideline embedded in there that [say] what is done in a proactive manner.”

This predictive tool came in handy recently at the dawn of the coronavirus pandemic. The health system was able to identify its most vulnerable 200,000 patients that the virus was spreading to and tell them to stay in their homes. 

“Our doctors have personally called these hundreds and thousands of people [to say] 'Here is my number don’t come in. The risk is too great. We will sort it out through online care, telephone or house visits,'” he said. 

Today Israel continues to have a relatively low coronavirus death count, at 281 – something that he attributes to both predictive care and the young population. 

 
 
ADVERTISEMENT
The College of St. Scholastica
 
 
 
The company has expanded to include more virtual care options after the coronavirus pandemic.

Keep Reading >>
 
 
 
The platform has been installed across all 124 Ministry of Defence sites internationally.

Keep Reading >>
 
 
 
The company said that its SmartExam product has seen more use in the first quarter of 2020 than all of 2019.

Keep Reading >>
 
 
 
Telemedicine has experienced a huge surge in adoption over the past few months, during the coronavirus pandemic. With people locked down at home, it has become the 'new normal' way of accessing healthcare says digital health connector, Aline Noizet.

Keep Reading >>
 
 
 
Kevin Phillips, VP of product management at Capsule, discusses the use of digital tools to stream data from tools ranging from ventilators to monitors.

Keep Reading >>
 
 
By HIMSS Insights
 
There is a renaissance of wearables in digital healthcare. More and more of them, many AI-empowered, are finding their way into serious clinical trials, thus contributing to medical evidence and ultimately better patient care. But with data comes responsibility: The question of how to design a digital healthcare data space that respects the privacy of individuals while at the same time providing maximal medical benefit is more important than ever.

Download the ebook now >>
 
 
ADVERTISEMENT
HIMSS Analytics
 
HIMSS20 Digital Coverage
 
EXCLUSIVE COVERAGE
 
Now and in the weeks ahead, HIMSS20 Digital will be featuring an array of presentations that had been planned for the 2020 HIMSS Global Health Conference & Exhibition – enabling registrants to view them on demand. We'll also be showcasing stories that highlight technology's ongoing and essential role in combating the worldwide COVID-19 pandemic. This is a pivotal moment for professionals across the global health ecosystem. So check back here regularly for must-have insights about new technologies, trends, policies and other healthcare innovations.
 
 
 
 
 
2 Monument Sq., Ste 400 Portland, ME 04101